Link Pharma Chem Limited, a pharmaceutical company listed on the Bombay Stock Exchange (BSE: 524748), held its 40th Annual General Meeting (AGM) on September 9, 2025, where shareholders approved several key resolutions, including the re-appointment of Mrs. Rachna Manav Ghai as a Woman Independent Director.

Re-appointment of Independent Director

The shareholders approved the re-appointment of Mrs. Rachna Manav Ghai (DIN: 08885422) as a Woman Independent Director for a second term of five consecutive years, effective from September 14, 2025, to September 13, 2030. This special resolution was passed with unanimous support from both promoter and public shareholders.

Director's Profile

Mrs. Ghai brings a wealth of experience to the board:

• Educational Background: First-class Bachelor of Science degree (1997) and Post Graduate Diploma in Business Management (PGDBM) (1998)
• Areas of Expertise: Education and general administration
• Independence: Meets the criteria of independence as prescribed under the Companies Act, 2013 and SEBI regulations
• Relationship with Company: Not related to any Directors, Key Managerial Personnel, or Promoters of Link Pharma Chem Limited

AGM Highlights

The 40th AGM, conducted through Video Conferencing (VC) and Other Audio-Visual Means (OAVM), saw the participation of 44 members, including corporate representatives. Key points from the meeting include:

1. Adoption of financial statements for the year ended March 31, 2025
2. Re-appointment of Mr. Rishikesh Thakur (DIN: 08777265) as a director
3. Ratification of remuneration for Cost Auditors for the financial year 2025-2026

Voting Results

All resolutions presented at the AGM were passed with the requisite majority. The e-voting results showed strong support from both promoter and public shareholders:

The meeting, which commenced at 11:40 AM, concluded at 12:10 PM, with Mr. Rishikesh Thakur, Managing Director, chairing the proceedings in place of Mr. Satish Thakur, who was unable to attend due to health reasons.

Link Pharma Chem Limited continues to demonstrate its commitment to corporate governance and shareholder engagement through these proceedings, ensuring transparency and compliance with regulatory requirements.

Link Pharma Chem Limited , a manufacturer and seller of chemicals, has reported a significant turnaround in its financial performance for the quarter ended June 30. The company's Board of Directors also approved the reappointment of Mrs. Rachna Manav Ghai as Woman Independent Director for a second term.

Financial Performance

The company's unaudited financial results for Q1 show a marked improvement:

Link Pharma Chem reported a net profit of Rs 40.19 lakhs for the quarter, compared to a loss of Rs 35.02 lakhs in the previous quarter. This represents a significant turnaround in the company's profitability.

Revenue from operations increased to Rs 781.48 lakhs, up from Rs 644.66 lakhs in the previous quarter, indicating a growth of 21.22% quarter-on-quarter. However, it's worth noting that the revenue is lower compared to the same quarter last year, which stood at Rs 884.63 lakhs.

The total income for the quarter reached Rs 802.40 lakhs, showing an improvement from Rs 656.45 lakhs in the previous quarter.

Operational Highlights

The company's operations continue to fall under a single segment, namely "Manufacture and Sale of Chemicals." This focus has likely contributed to the improved financial performance in the quarter.

Board Decisions

In addition to approving the financial results, the Board of Directors made a significant decision regarding the company's leadership:

Reappointment of Independent Director

The Board approved the reappointment of Mrs. Rachna Manav Ghai (DIN: 08885422) as a Woman Independent Director. Her second term will span five years, from September 14, 2025, to September 13, 2030, subject to shareholder approval at the upcoming general meeting.

Mrs. Ghai, who holds a first-class Bachelor of Science degree (1997) and a Post Graduate Diploma in Business Management (1998), brings valuable experience in education and general administration to the board.

Looking Ahead

While Link Pharma Chem has shown a strong recovery in profitability this quarter, the company will need to focus on sustaining this momentum and potentially recapturing the revenue levels seen in the previous year. The reappointment of Mrs. Ghai as an Independent Director suggests a commitment to maintaining strong corporate governance practices.

Investors and stakeholders will likely be watching closely to see if the company can build on this positive performance in the coming quarters.